DRUGS AND ENDOGENOUS LIGANDS COMPETE FOR RECEPTOR OCCUPANCY

被引：5
|
作者：
COLBURN, WA
机构：
[1] Harris Laboratories, Inc., Clinical Development Division, Phoenix, AZ 85040
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1994年 / 34卷 / 12期
关键词：
D O I：
10.1002/j.1552-4604.1994.tb04724.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Dietary and endogenous ligands compete with drugs for receptor occupancy and therefore should be considered during therapeutic interventions and during pharmacokinetic/ pharmacodynamic modeling. When disease is the result of an overabundance of these natural ligands, antibodies and/or their Fab fragments may be useful as therapeutic agents to reverse the effects of the natural ligands.
引用
收藏
页码：1148 / 1152
页数：5
相关论文
共 50 条
  • [31] On the relationship between inhibition and receptor occupancy by nondepolarizing neuromuscular blocking drugs
    Hoshino, Hikaru
    Furutani, Eiko
    THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2021, 18 (01)
  • [32] QUANTITATIVE ANALYSIS OF THE RECEPTOR OCCUPANCY BY CNS ACTING DRUGS IN HUMAN BRAIN
    Kusuhara, Hiroyuki
    DRUG METABOLISM REVIEWS, 2015, 47 : 21 - 21
  • [33] Leukotriene A4 metabolites are endogenous ligands for the Ah receptor
    Chiaro, Christopher R.
    Morales, J. Luis
    Prabhu, K. Sandeep
    Perdew, Gary H.
    BIOCHEMISTRY, 2008, 47 (32) : 8445 - 8455
  • [34] Effects of xenobiotic versus endogenous ligands on the aryl hydrocarbon receptor
    Tkachenko, A.
    Irmer-Stooff, S.
    Henkler, F.
    Luch, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S79 - S79
  • [35] Endogenous retinoid X receptor ligands in mouse hematopoietic cells
    Niu, Haixia
    Fujiwara, Hideji
    di Martino, Orsola
    Hadwiger, Gayla
    Frederick, Thomas E.
    Menendez-Gutierrez, Maria P.
    Ricote, Mercedes
    Bowman, Gregory R.
    Welch, John S.
    SCIENCE SIGNALING, 2017, 10 (503)
  • [36] Endogenous bile acids are ligands for the nuclear receptor FXR BAR
    Wang, HB
    Chen, J
    Hollister, K
    Sowers, LC
    Forman, BM
    MOLECULAR CELL, 1999, 3 (05) : 543 - 553
  • [37] Building on endogenous lipid mediators to design synthetic receptor ligands
    Chen, Luying
    Yan, Ge
    Ohwada, Tomohiko
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 231
  • [38] Screening of endogenous ligands for Toll-like receptor 3
    Yang, EJ
    Shin, JS
    Choi, IH
    FASEB JOURNAL, 2005, 19 (04): : A376 - A376
  • [39] Are cannabinoids endogenous ligands for the VR1 capsaicin receptor?
    Szolcsányi, J
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) : 41 - 42
  • [40] Are angiotensin peptide fragments endogenous ligands for the AT2 receptor?
    Widdop, Robert E.
    Walters, Pia E.
    Gaspari, Tracey A.
    JOURNAL OF HYPERTENSION, 2006, 24 : 186 - 186
12345